...
首页> 外文期刊>The journal of clinical endocrinology and metabolism >The Role of Glutamic or Aspartic Acid in Position Four of the Epitope Binding Motif and Thyrotropin Receptor-Extracellular Domain Epitope Selection in Graves’ Disease
【24h】

The Role of Glutamic or Aspartic Acid in Position Four of the Epitope Binding Motif and Thyrotropin Receptor-Extracellular Domain Epitope Selection in Graves’ Disease

机译:谷氨酸或天冬氨酸在Graves病中表位结合基序的第4位和促甲状腺素受体-细胞外结构域表位选择中的作用

获取原文
           

摘要

Context: Development of Graves’ disease (GD) is related to HLA-DRB1*0301 (DR3),and more specifically to arginine at position 74 of the DRB1 molecule. The extracellular domain (ECD) of human TSH receptor (hTSH-R) contains the target antigen.Objective and Design: We analyzed the relation between hTSH-R-ECD peptides and DR molecules to determine whether aspartic acid (D) or glutamic acid (E) at position four in the binding motif influenced selection of functional epitopes.Results: Peptide epitopes from TSH-R-ECD with D or E in position four (D/E+) had higher affinity for binding to DR3 than peptides without D/E (D/E?) (IC_(50) 29.3 vs. 61.4, P = 0.0024). HLA-DR7, negatively correlated with GD, and DRB1*0302 (HLA-DR18), not associated with GD, had different profiles of epitope binding. Toxic GD patients who are DR3+ had higher responses to D/E+ peptides than D/E? peptides (stimulation index 1.42 vs. 1.22, P = 0.028). All DR3+ GD patients (toxic + euthyroid) had higher responses, with borderline significance (Sl; 1.32 vs. 1.18, P = 0.051). Splenocytes of DR3 transgenic mice immunized to TSH-R-ECD responded to D/E+ peptides more than D/E? peptides (stimulation index 1.95 vs. 1.69, P = 0.036). Seven of nine hTSH-R-ECD peptide epitopes reported to be reactive with GD patients’ peripheral blood mononuclear cells contain binding motifs with D/E at position four.Conclusions: TSH-R-ECD epitopes with D/E in position four of the binding motif bind more strongly to DRB1*0301 than epitopes that are D/E? and are more stimulatory to GD patients’ peripheral blood mononuclear cells and to splenocytes from mice immunized to hTSH-R. These epitopes appear important in immunogenicity to TSH-R due to their favored binding to HLA-DR3, thus increasing presentation to T cells.
机译:背景:格雷夫斯病(GD)的发展与HLA-DRB1 * 0301(DR3)有关,更具体地说,与DRB1分子第74位的精氨酸有关。目的和设计:我们分析了hTSH-R-ECD肽与DR分子之间的关系,以确定天冬氨酸(D)还是谷氨酸( E)结合基序中第4位会影响功能性表位的选择。结果:来自TSH-R-ECD的第4位具有D或E的肽表位(D / E +)比没有D / E的肽具有更高的结合DR3的亲和力。 (D / E2)(IC_(50)29.3对61.4,P = 0.0024)。与GD负相关的HLA-DR7和与GD不相关的DRB1 * 0302(HLA-DR18)具有不同的表位结合特征。 DR3 +的有毒GD患者对D / E +肽的反应要比D / E高?肽(刺激指数1.42 vs.1.22,P = 0.028)。所有DR3 + GD患者(毒性+甲状腺功能正常)均具有较高的反应,具有临界意义(S1; 1.32与1.18,P = 0.051)。用TSH-R-ECD免疫的DR3转基因小鼠的脾细胞对D / E +肽的反应比对D / E?肽(刺激指数1.95对1.69,P = 0.036)。据报道与GD患者外周血单核细胞有反应的9个hTSH-R-ECD肽表位中有7个在第4位具有D / E的结合基序。结论:在第4位具有D / E的TSH-R-ECD表位结合基序与DRB1 * 0301的结合比D / E?并且对GD患者的外周血单核细胞和经hTSH-R免疫的小鼠的脾细胞更具刺激性。这些表位由于它们对HLA-DR3的有利结合而在针对TSH-R的免疫原性中显得很重要,因此增加了对T细胞的呈递。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号